US 6426076
Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy
expired A61KA61K31/375A61K31/40
Quick answer
US patent 6426076 (Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy) held by PASCO Pharmazeutische Präparate GmbH expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- PASCO Pharmazeutische Präparate GmbH
- Grant date
- Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/375, A61K31/40, A61K31/475, A61K31/505